Epinephrine (also called adrenaline) is produced naturally in your adrenal glands and can also be manufactured synthetically through a multi-step chemical process. Whether you’re curious about how your body makes it or how pharmaceutical companies produce it at scale, the answer involves surprisingly complex chemistry that has evolved significantly since the compound was first isolated in 1901.
How Your Body Makes Epinephrine
Your adrenal glands sit on top of your kidneys and produce epinephrine through a four-step chemical assembly line, starting with the amino acid tyrosine, which you get from protein in your diet. Each step requires a specific enzyme to transform the molecule into the next intermediate.
First, an enzyme called tyrosine hydroxylase adds a chemical group to tyrosine, converting it into L-DOPA. This is the slowest step in the chain and acts as the bottleneck controlling how much epinephrine your body can produce at any given time. Next, a second enzyme strips a piece off L-DOPA to create dopamine, the same molecule involved in motivation and reward in the brain. A third enzyme then adds an oxygen-containing group to dopamine’s side chain, producing norepinephrine. Finally, a fourth enzyme attaches a small carbon-containing tag to norepinephrine, completing the transformation into epinephrine.
This pathway is shared across several important signaling molecules. Dopamine, norepinephrine, and epinephrine are all part of the same family (catecholamines), and different cells in your body stop at different points along the chain depending on which enzymes they contain. Only cells that have all four enzymes, primarily those in the inner part of the adrenal glands, produce epinephrine itself.
Historical Extraction From Animal Glands
In 1901, Japanese chemist Jokichi Takamine became the first person to extract epinephrine from the adrenal glands of animals. This involved grinding up suprarenal glands (typically from cattle), dissolving the tissue in acidic solutions, and isolating the active compound through a series of purification steps. Just three years later, in 1904, Friedrich Stolz achieved the first fully synthetic production of epinephrine, eliminating the need for animal tissue entirely.
Animal extraction was inefficient and difficult to standardize, which is why synthetic production quickly became the preferred method and remains so today.
Modern Industrial Synthesis
Pharmaceutical manufacturers don’t follow the same pathway your body uses. Instead, they build the epinephrine molecule through industrial organic chemistry, starting from simpler and cheaper raw materials. One well-documented process begins with catechol, a simple two-ringed chemical, and chloroacetyl chloride. These are combined in the presence of a catalyst (typically aluminum chloride or zinc chloride) to form the initial backbone of the molecule.
In the next step, a nitrogen-containing compound is attached to introduce the amine group that gives epinephrine its biological activity. The intermediate molecule then undergoes a reaction using hydrogen gas and a metal catalyst, often palladium or platinum on a carbon support, to remove a protective chemical group and reduce the molecule into its final form.
One significant challenge in synthetic production is that the chemical process creates a 50/50 mixture of two mirror-image forms of the molecule. Only one of these forms, the “L” or levorotatory version, is biologically active. Separating the active form from its inactive mirror image has proven difficult. Attempts to split the mixture using tartaric acid (a classic technique in chemistry) yield only limited enrichment of the desired form because the two versions form a solid solution that resists clean separation by crystallization. Manufacturers use more sophisticated resolution techniques to achieve the purity required for pharmaceutical use.
Turning Raw Epinephrine Into Medicine
Producing the raw chemical is only half the challenge. Converting bulk epinephrine into a safe, stable injectable product requires precise formulation. A standard 1 mg/mL injectable solution contains epinephrine dissolved in water along with sodium chloride (8.6 mg per milliliter to match the salt concentration of blood) and hydrochloric acid to dissolve the compound and adjust the pH to between 2.2 and 5.0. Some formulations historically included sodium bisulfite as an antioxidant preservative, though current FDA-labeled ampule formulations contain no preservatives or sulfites.
Before reaching patients, the active ingredient must pass extensive quality testing. FDA review documents show that manufacturers test for purity, optical rotation (confirming the correct mirror-image form), moisture content, residual solvents, and levels of specific impurities like norepinephrine and adrenalone. The limit for adrenalone, a degradation product, is set below 0.41%, which is stricter than the baseline pharmacopeia requirement.
Why Epinephrine Degrades So Easily
Epinephrine is remarkably fragile for such a powerful molecule. It breaks down when exposed to oxygen, light, or alkaline conditions. This sensitivity is why the label instructions for pharmaceutical epinephrine specifically state to protect it from alkalis and oxidizing agents.
In sealed auto-injectors that block light and air, epinephrine remains stable for at least a year. But the picture changes dramatically when the drug is transferred into syringes. In one study, epinephrine diluted to 0.1 mg/mL and stored in syringes with capped needles attached showed significant degradation after just 7 days, likely because the needle allowed enough air exposure to trigger oxidation. In contrast, another study stored the same concentration in syringes sealed with plastic caps inside light-proof pouches and found no significant degradation over 24 weeks.
The practical takeaway from this research is that storage conditions matter enormously. Pharmaceutical epinephrine should be kept at room temperature (20 to 25°C), protected from light, and sealed against air exposure. Even small differences in how tightly a container is sealed can determine whether the drug remains effective for days or months.
Why This Can’t Be Done at Home
Every step of epinephrine production, from synthesis through formulation, requires industrial chemistry equipment, regulated precursor chemicals, metal catalysts, hydrogen gas under pressure, sterile manufacturing environments, and analytical instruments to verify purity and correct molecular form. The synthesis involves hazardous reagents (chloroacetyl chloride is highly corrosive, Lewis acid catalysts are reactive, and hydrogen gas is flammable), and the resolution of mirror-image forms demands techniques beyond standard laboratory capability.
Beyond the chemistry itself, injectable medications must be sterile and free of particulates, endotoxins, and impurities at levels measurable only with specialized equipment. An impure or incorrectly formulated epinephrine product could contain the wrong mirror-image form (which is inactive), degradation products, residual solvents, or bacterial contamination. Pharmaceutical-grade epinephrine exists precisely because these risks require controlled manufacturing and rigorous testing to eliminate.